Document ID: chunk:federal_register_of_legislation:F2025L00066:schedule:1
Version: federal_register_of_legislation:F2025L00066
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2254–3253

Schedule 1—Amendments

National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021)
 1.                    Schedule 1, entry for Adalimumab in the form Injection 40 mg in 0.4 mL pre‑filled syringe
     omit:
         Adalicip  C12120 C14061 C14063 C14064 C14107 C14136     See Schedule 2  See Schedule 2

 1.                    Schedule 1, entry for Maraviroc in each of the forms: Tablet 150 mg; and Tablet 300 mg
     insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         Maraviroc Waymade  C5008     120  5

 1.                    Schedule 1, entry for Tenofovir in the form Tablet containing tenofovir disoproxil maleate 300 mg
         1.            omit:
         Tenofovir Disoproxil Mylan  C6980 C6982 C6983 C6984 C6992 C6998 C10362  P10362  60  2

          1.            omit:
         Tenofovir Disoproxil Mylan  C6980 C6982 C6983 C6984 C6992 C6998 C10362  P6980 P6982 P6983 P6984 P6992 P6998  60  5